Quadrant Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-29,568
| Closed | -$1.53M | – | 64 |
|
|
2016
Q1 | $1.53M | Buy |
29,568
+4,372
| +17% | +$226K | 1.3% | 40 |
|
|
2015
Q4 | $1.77M | Buy |
25,196
+600
| +2% | +$42.1K | 1.43% | 34 |
|
|
2015
Q3 | $1.53M | Buy |
24,596
+1,070
| +5% | +$66.6K | 1.3% | 37 |
|
|
2015
Q2 | $1.98M | Sell |
23,526
-1,080
| -4% | -$90.8K | 1.69% | 30 |
|
|
2015
Q1 | $1.85M | Sell |
24,606
-489
| -2% | -$36.8K | 1.59% | 33 |
|
|
2014
Q4 | $1.56M | Buy |
25,095
+45
| +0.2% | +$2.8K | 1.34% | 38 |
|
|
2014
Q3 | $1.3M | Buy |
25,050
+300
| +1% | +$15.6K | 1.24% | 42 |
|
|
2014
Q2 | $1.27M | Buy |
+24,750
| New | +$1.27M | 1.22% | 43 |
|